These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 2199801

  • 21. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 22. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 23. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 24. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 25. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ, Stuyt PM, Demacker PN, Stalenhoef AF.
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [Abstract] [Full Text] [Related]

  • 26. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Apr; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 27. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR.
    Minerva Med; 1992 Jun; 83(6):347-53. PubMed ID: 1630695
    [Abstract] [Full Text] [Related]

  • 28. [Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Ditschuneit HH, Dreyer M, Dammann HG, Ditschuneit H.
    Med Klin (Munich); 1991 Mar 15; 86(3):142-8. PubMed ID: 1903497
    [Abstract] [Full Text] [Related]

  • 29. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 15; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 30. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb 15; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 31. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Feb 15; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 32. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 33. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW, Van Erpecum KJ, Portincasa P, Renooij W, Erkelens DW, Van Berge-Henegouwen GP.
    Gut; 1995 Nov 15; 37(5):654-9. PubMed ID: 8549941
    [Abstract] [Full Text] [Related]

  • 34. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 35. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Feb 28; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 36. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar 28; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 37. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Mar 28; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 38. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM, Katyal A.
    Mo Med; 2002 Mar 28; 99(10):580-4. PubMed ID: 12534147
    [Abstract] [Full Text] [Related]

  • 39. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 28; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 40. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Sep 28; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.